Trial · NCT05205759
Non-inferiority Trial on Monoclonal Antibodies in COVID-19
NCT05205759, Phase 3, Terminated, Azienda Ospedaliera Universitaria Integrata Verona
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Non-inferiority Trial on Monoclonal Antibodies in COVID-19. Trials, record NCT05205759. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05205759
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Non-inferiority Trial on Monoclonal Antibodies in COVID-19
- NCT number
- NCT05205759
- Status
- Terminated
- Phases
- Phase 3
- Enrollment
- 319 participants, actual
- Lead sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Conditions
- COVID-19
- Interventions
- Bamlanivimab Etesevimab, Sotrovimab, Casirivimab-Imdevimab
- First posted
- 2022-01-25
- Last updated
- 2022-07-26
- Other registries' IDs
- eudract:2021-002612-31
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | COVID-19 progression | 14 days | (1) hospitalization or (2) need of supplemental oxygen therapy at home or (3) death within 14 days of randomisation |
| Secondary | Visits to the Emergency Room | 28 days | Number of visits to the Emergency Room without subsequent hospitalization within 28 days of randomization |
| Secondary | Duration of supplemental oxygen therapy | 90 days | Days of supplemental oxygen therapy within 90 days of randomization |
| Secondary | Duration of hospitalization | 90 days | Days of any hospitalization within 90 days of randomization |
| Secondary | Non-invasive ventilation | 28 days | Rate of patients undergoing non-invasive ventilation within 28 days of randomization |
| Secondary | Duration of non-invasive ventilation | 90 days | Days of non-invasive ventilation within 90 days of randomization |
| Secondary | Mechanical ventilation | 28 days | Rate of patients undergoing mechanical ventilation within 28 of randomization |
| Secondary | Duration of mechanical ventilation | 90 days | Days of mechanical ventilation within 90 days of randomization |
| Secondary | 28-day mortality | 28 days | Death rate at 28 days of randomization |
| Secondary | Duration of symptoms | 90 days | Days of symptoms within 90 days of randomization |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05205759
GET https://conductscience.org/api/trials/v1/NCT05205759/registered